Gossamer Bio Inc
General ticker "GOSS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $173.9M
Gossamer Bio Inc does not follow the US Stock Market performance with the rate: -1.7%.
Estimated limits based on current volatility of 5.5%: low 0.77$, high 0.86$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.56$, 1.70$]
- 2024-12-30 to 2025-12-30 estimated range: [0.86$, 2.28$]
Financial Metrics affecting the GOSS estimates:
- Negative: Non-GAAP EPS, $ of -1.39 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -53.12 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Interest expense per share, $ of 0.09 <= 0.14
Short-term GOSS quotes
Long-term GOSS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $216.12MM | $218.59MM | $183.76MM |
| Operating Income | $-216.12MM | $-218.59MM | $-183.76MM |
| Non-Operating Income | $-17.88MM | $-10.79MM | $3.94MM |
| Interest Expense | $19.44MM | $13.88MM | $13.51MM |
| R&D Expense | $170.27MM | $170.92MM | $145.30MM |
| Income(Loss) | $-234.00MM | $-229.38MM | $-179.82MM |
| Profit(Loss) | $-234.00MM | $-229.38MM | $-179.82MM |
| Stockholders Equity | $121.46MM | $12.08MM | $62.77MM |
| Inventory | $0.14MM | $0.00MM | $0.00MM |
| Assets | $343.66MM | $272.45MM | $311.92MM |
| Operating Cash Flow | $-188.89MM | $-187.03MM | $-159.16MM |
| Capital expenditure | $1.62MM | $0.47MM | $0.00MM |
| Investing Cash Flow | $-117.43MM | $-1.03MM | $-110.97MM |
| Financing Cash Flow | $3.33MM | $117.09MM | $190.15MM |
| Earnings Per Share* | $-3.33 | $-2.84 | $-1.18 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.